Can Bank of America Sustain Revenue Growth on Stronger Loans & NII?

Bank of America expects 2026 net interest income growth of 7-8%, supported by mid- to upper-single-digit commercial loan growth, deposit growth and repricing of fixed-rate assets. Management cited greater confidence in its 2.3% medium-term net interest margin target after the Fed's 25bp rate increase to 3.75-4.00%, while BAC's roughly $2 trillion deposit base supports funding advantages. Offsetting factors include expected Q3 2026 investment-banking fees of $1.6-$1.8B versus $2.0B a year earlier and flat trading revenue, although wealth/AUM fees are projected to rise 10-15% year over year.

Analysis

BAC's setup is more rate-duration-sensitive than the article implies: incremental asset repricing can lift earnings while deposit costs remain contained, but the same curve/rate backdrop makes its large securities book and unrealized-loss sensitivity a valuation constraint. The relevant catalyst is not management's NII target but whether quarterly deposit beta stays below expectations as commercial balances grow; that would permit 2027 consensus EPS to move higher and narrow BAC's discount to JPM. Over the next 1-3 months, a beat driven solely by NII is unlikely to command a full multiple rerating if investment-banking and trading remain soft.

The competitive read favors universal banks with low-cost deposit franchises over capital-markets-heavy peers. JPM has better earnings diversification and execution consistency, whereas BAC offers greater operating leverage to a stable-to-higher front end and a normalization of its fixed-income asset yield; MS is the cleaner wealth/markets expression if risk assets remain strong. A second-order risk is that broad commercial loan growth late in a restrictive cycle can be a lagging indicator: credit normalization in CRE, leveraged corporate borrowers, or small business would erase the benefit through provisions well before charge-offs become visibly elevated.

Consensus may be underweight BAC's upside to a benign higher-for-longer outcome but overstates the value of headline loan growth without loan-yield, utilization, deposit-mix, and reserve data. For the 6-18 month view, the bull case requires both a steeper/less inversion-prone curve and no material deterioration in criticized commercial credits. Falsify the constructive view if NII guidance is cut, deposit costs accelerate faster than asset yields for two consecutive quarters, or provision growth materially exceeds loan growth.

Key Decisions for Investors

• Initiate a 3-6 month long BAC / short JPM pair only on BAC underperformance around results: BAC offers more NII and balance-sheet normalization leverage, while JPM hedges sector beta. Target 8-12% relative upside; exit if BAC's NII outlook is reduced or reserve build exceeds roughly 20% year over year.
• For outright exposure, accumulate BAC after earnings only if management discloses stable deposit beta and commercial-loan yields rising sequentially; target a rerating toward 2.2-2.3x tangible book over 6-12 months versus 1.97x cited. Do not chase a headline NII beat absent those datapoints.
• Maintain MS over BAC if the next quarter's market-sensitive fee pipeline accelerates: MS has superior upside to sustained equity-market strength and wealth flows, while BAC's fee mix provides less offset if loan demand weakens. Reassess on a meaningful risk-asset drawdown or evidence of rising BAC deposit costs.
• Set a credit-risk watch on BAC's commercial portfolio disclosures rather than adding financial-sector beta broadly. A sequential rise in criticized exposures, CRE modifications, or net charge-offs would favor reducing BAC and rotating toward JPM, whose diversified earnings base better absorbs a late-cycle provision reset.